Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
28.46
+0.50 (1.79%)
At close: Aug 31, 2026, 4:00 PM EDT
28.51
+0.05 (0.18%)
After-hours: Aug 31, 2026, 7:59 PM EDT
Pfizer Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Revenue Revenue Growth | 15,034 | 14,451 | 17,557 | 16,654 | 14,653 | 13,715 | 17,763 | 17,702 | 13,283 | 14,878 | 14,569 | 13,492 | 13,007 | 18,485 | 24,290 | 22,638 | 27,742 | 25,661 | 23,838 | 24,035 |
Revenue Growth | 2.60% | 5.37% | -1.16% | -5.92% | 10.31% | -7.82% | 21.92% | 31.20% | 2.12% | -19.51% | -40.02% | -40.40% | -53.11% | -27.96% | 1.90% | -5.81% | 46.79% | 76.78% | 108.61% | 133.87% |
Gross Profit Gross Profit Growth | 11,379 | 11,044 | 12,492 | 12,675 | 11,152 | 11,123 | 11,250 | 12,829 | 10,515 | 11,842 | 13,503 | 4,587 | 9,935 | 13,738 | 14,815 | 16,601 | 19,117 | 15,703 | 14,127 | 14,135 |
Operating Income Operating Income Growth | 4,191 | 4,569 | 4,204 | 5,875 | 4,204 | 4,823 | 2,046 | 5,838 | 2,973 | 4,706 | 5,335 | -2,386 | 2,788 | 6,865 | 6,216 | 10,148 | 12,286 | 10,349 | 6,745 | 8,827 |
Net Income Net Income Growth | -248 | 2,687 | -1,648 | 3,541 | 2,910 | 2,967 | 410 | 4,465 | 41 | 3,115 | -3,369 | -2,382 | 2,327 | 5,543 | 4,994 | 8,608 | 9,906 | 7,864 | 3,393 | 8,146 |
Earnings Per Share EPS Growth | -0.04 | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 | 0.07 | 0.79 | 0.01 | 0.55 | -0.60 | -0.42 | 0.41 | 0.97 | 0.87 | 1.51 | 1.74 | 1.37 | 0.59 | 1.43 |
EPS Growth | - | -10.05% | - | -21.31% | 6973.98% | -5.30% | - | - | -98.23% | -43.40% | - | - | -76.40% | -29.10% | 47.11% | 5.50% | 77.42% | 59.09% | 289.72% | 450.37% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Primary Care Primary Care Growth | 5,503 | 5,542 | 7,938 | 7,646 | 5,535 | 5,692 | 8,911 | 9,060 | 4,952 | 7,211 | 7,044 | 6,310 | 5,884 | 11,560 | 17,348 | 15,846 | 20,979 | 18,851 | 16,225 | 16,680 |
Oncology Oncology Growth | 4,165 | 3,826 | - | - | 4,034 | 3,494 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Specialty Care Specialty Care Growth | 3,353 | 2,939 | - | - | 3,089 | 2,616 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Hospital and Biosimilars Hospital and Biosimilars Growth | 1,640 | 1,854 | - | - | 1,647 | 1,639 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Business Innovation (Pfizer CentreOne) Business Innovation (Pfizer CentreOne) Growth | 373 | 289 | 409 | 344 | 348 | 273 | 325 | 285 | 278 | 258 | 364 | 293 | 307 | 308 | 368 | 319 | 317 | 338 | 382 | 521 |
Revenue (Total) Revenue (Total) Growth | 15,034 | 14,451 | 17,557 | 16,654 | - | 13,715 | 17,763 | 17,702 | 13,283 | 14,879 | 14,569 | 13,491 | 13,007 | 18,486 | 25,135 | 22,638 | 27,742 | 25,661 | 23,838 | 24,035 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Cash & Investments Cash & Investments Growth | 11,704 | 13,081 | 13,596 | 14,986 | 13,249 | 17,319 | 20,477 | 9,953 | 7,100 | 11,929 | 12,690 | 44,182 | 44,785 | 19,972 | 22,732 | 36,132 | 33,312 | 23,902 | 31,073 | 29,702 |
Total Debt Total Debt Growth | 63,480 | 64,731 | 67,647 | 61,938 | 62,044 | 62,397 | 67,418 | 67,945 | 69,858 | 69,902 | 75,332 | 64,133 | 65,674 | 36,166 | 39,377 | 36,999 | 40,490 | 36,441 | 41,395 | 39,879 |
Net Cash (Debt) Net Cash Growth | -51,776 | -51,650 | -54,051 | -46,952 | -48,795 | -45,078 | -46,941 | -57,992 | -62,758 | -57,973 | -62,642 | -19,951 | -20,889 | -16,194 | -16,645 | -867 | -7,178 | -12,539 | -10,322 | -10,177 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.09 | -9.01 | -9.51 | -8.22 | -8.55 | -7.89 | -8.23 | -10.17 | -11.02 | -10.18 | -11.09 | -3.53 | -3.66 | -2.83 | -2.90 | -0.15 | -1.26 | -2.18 | -1.79 | -1.78 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 835 | 2,615 | 5,348 | 4,603 | - | 2,335 | 6,721 | 6,714 | -1,781 | 1,090 | 5,240 | 3,456 | -1,208 | 1,212 | 8,582 | 5,974 | 8,170 | 6,541 | 5,914 | 10,829 |
Capital Expenditures CapEx Growth | -533 | -436 | -845 | -602 | - | -564 | -917 | -651 | -637 | -704 | -1,044 | -810 | -914 | -1,139 | -1,001 | -841 | -751 | -643 | -1,002 | -618 |
Free Cash Flow Free Cash Flow Growth | 302 | 2,179 | 4,503 | 4,001 | - | 1,771 | 5,804 | 6,063 | -2,418 | 386 | 4,196 | 2,646 | -2,122 | 73 | 7,581 | 5,133 | 7,419 | 5,898 | 4,912 | 10,211 |
Free Cash Flow Growth | - | 23.04% | -22.42% | -34.01% | - | 358.81% | 38.32% | 129.14% | - | 428.77% | -44.65% | -48.45% | - | -98.76% | 54.34% | -49.73% | -31.06% | 48.04% | 2.08% | 545.04% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Gross Margin | 75.69% | 76.42% | 71.15% | 76.11% | 76.11% | 81.10% | 63.33% | 72.47% | 79.16% | 79.59% | 92.68% | 34.00% | 76.38% | 74.32% | 60.99% | 73.33% | 68.91% | 61.19% | 59.26% | 58.81% |
Operating Margin | 27.88% | 31.62% | 23.95% | 35.28% | 28.69% | 35.17% | 11.52% | 32.98% | 22.38% | 31.63% | 36.62% | -17.69% | 21.44% | 37.14% | 25.59% | 44.83% | 44.29% | 40.33% | 28.29% | 36.73% |
Pretax Margin | -4.34% | 21.93% | -9.35% | 20.02% | 20.77% | 20.30% | -0.06% | 26.64% | -0.78% | 22.99% | -28.34% | -24.84% | 17.44% | 33.92% | 21.53% | 39.76% | 41.27% | 35.27% | 16.05% | 32.63% |
Profit Margin | -1.65% | 18.59% | -9.39% | 21.26% | 19.86% | 21.63% | 2.31% | 25.22% | 0.31% | 20.94% | -23.12% | -17.66% | 17.89% | 29.99% | 20.56% | 38.02% | 35.71% | 30.65% | 14.23% | 33.89% |
FCF Margin | 2.01% | 15.08% | 25.65% | 24.02% | - | 12.91% | 32.67% | 34.25% | -18.20% | 2.59% | 28.80% | 19.61% | -16.31% | 0.40% | 31.21% | 22.67% | 26.74% | 22.98% | 20.61% | 42.48% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.430 | 0.430 | 0.860 | 0.430 | 0.430 | 0.430 | 0.840 | 0.420 | 0.420 | 0.420 | 0.410 | 0.410 | 0.410 | 0.410 | 0.400 | 0.400 | 0.400 | 0.400 | 0.390 | 0.390 |
Dividend Per Share Growth | 0% | 0% | 2.38% | 2.38% | 2.38% | 2.38% | 104.88% | 2.44% | 2.44% | 2.44% | 2.50% | 2.50% | 2.50% | 2.50% | 2.56% | 2.56% | 2.56% | 2.56% | 2.63% | 2.63% |
Dividend Yield | 9.01% | 8.22% | 9.08% | 9.59% | 9.54% | 9.29% | 8.93% | 6.57% | 6.89% | 7.01% | 6.82% | 5.96% | 5.42% | 4.89% | 3.91% | 4.58% | 3.84% | 3.90% | 3.41% | 4.70% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 29, 2025 | Mar '25 Mar 30, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 3, 2021 |
PE Ratio | - | 20.54 | - | 13.75 | 12.79 | 18.14 | 18.72 | 38.77 | - | - | - | - | 9.64 | 7.93 | 9.17 | 8.25 | 10.01 | 11.62 | 15.08 | 12.39 |
Forward PE | 8.54 | 9.13 | 8.54 | 8.46 | 8.59 | 8.55 | 9.91 | 11.18 | 12.28 | 12.54 | 19.25 | 10.94 | 11.49 | 11.95 | 10.82 | 7.65 | 7.78 | 7.17 | 10.64 | 9.82 |
P/FCF Ratio | 12.60 | 14.40 | 13.78 | 11.67 | - | 12.74 | 15.29 | 20.04 | - | 30.78 | 33.92 | 22.90 | - | 11.40 | 11.05 | 10.51 | 10.32 | 9.12 | 11.10 | 8.09 |
PS Ratio | 2.17 | 2.43 | 2.26 | 2.15 | 2.15 | 2.29 | 2.36 | 2.73 | 2.82 | 2.81 | 2.73 | 2.70 | 2.64 | 2.47 | 2.87 | 2.46 | 2.90 | 3.14 | 4.08 | 3.50 |